APC anti-human TCR α/β Antibody
- 产品名称：
- APC anti-human TCR α/β Antibody
- 产品类别：
- 抗体
- 产品编号：
- 306717
- 产品应用：
- 306717
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1356 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: T cell activation. When co-staining with anti-CD3, we recommend using clone UCHT1, since we have confirmed that IP26 does not compete with this clone. ?Other anti-CD3 clones may compete out the binding of IP26. ?
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York. (FC)
- Joseph A, et al. 2008. J. Virol. 82:3078. (FC) PubMed
- Pinto JP, et al. 2010. Immunology. 130:217. PubMed
- Product Citations
-
- Guo X, et al. 2016. Mol Ther Methods Clin Dev. 3:15054. PubMed
- Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
- Ahmed R et al. 2019. Cell. 177(6):1583-1599 . PubMed
- Wang Z, et al. 2021. Cell Mol Immunol. 18:2188. PubMed
- Jiménez–Reinoso A, et al. 2018. J Allergy Clin Immunol. 141:1151. PubMed
- Ollé Hurtado M, et al. 2019. PLoS One. 14:e0216373. PubMed
- Fisher J, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.03.002. PubMed
- Japp AS, et al. 2021. Cell. 184(3):827-839.e14. PubMed
- Warmuth S, et al. 2022. Oncoimmunology. 10:2004661. PubMed
- Congras A, et al. 2020. J Clin Invest. 130:6395. PubMed
- James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed
- Bear AS, et al. 2021. Nat Commun. 12:4365. PubMed
- Ferry GM, et al. 2022. Front Immunol. 13:863155. PubMed
- Rosskopf S, et al. 2018. Oncotarget. 9:17608. PubMed
- Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
- Frasca D, et al. 2018. PLoS One. 13:e0197472. PubMed
- Lavaert M, et al. 2020. Frontiers in Immunology. 1.610416667. PubMed
- Omer B, et al. 2019. Front Med (Lausanne). 5:343. PubMed
- RRID
- AB_10612747 (BioLegend Cat. No. 306717) AB_10612569 (BioLegend Cat. No. 306718)
